Carol Forsblom

19.3k total citations · 1 hit paper
276 papers, 12.2k citations indexed

About

Carol Forsblom is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Genetics. According to data from OpenAlex, Carol Forsblom has authored 276 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Endocrinology, Diabetes and Metabolism, 74 papers in Nephrology and 67 papers in Genetics. Recurrent topics in Carol Forsblom's work include Diabetes Management and Research (83 papers), Chronic Kidney Disease and Diabetes (59 papers) and Diabetes Treatment and Management (52 papers). Carol Forsblom is often cited by papers focused on Diabetes Management and Research (83 papers), Chronic Kidney Disease and Diabetes (59 papers) and Diabetes Treatment and Management (52 papers). Carol Forsblom collaborates with scholars based in Finland, Australia and United States. Carol Forsblom's co-authors include Per‐Henrik Groop, Markku Saraheimo, Lena M. Thorn, Valma Harjutsalo, Johan Wadén, Leif Groop, Daniel Gordin, Merlin C. Thomas, Milla Rosengård‐Bärlund and Marja‐Riitta Taskinen and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Carol Forsblom

274 papers receiving 11.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes

2009 463 citations Per‐Henrik Groop, Lena M. Thorn et al. Diabetes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol Forsblom Finland	60	5.2k	2.9k	2.5k	2.4k	2.3k	276	12.2k
Andrzej S. Królewski United States	63	5.8k 1.1×	3.2k 1.1×	3.2k 1.3×	3.1k 1.3×	5.3k 2.2×	190	15.7k
Barry I. Freedman United States	65	3.2k 0.6×	3.0k 1.0×	1.8k 0.7×	3.3k 1.3×	6.2k 2.6×	420	16.3k
Michel Marre France	66	8.7k 1.7×	2.2k 0.7×	3.3k 1.3×	3.9k 1.6×	2.3k 1.0×	423	17.2k
Lise Tarnow Denmark	63	5.2k 1.0×	1.2k 0.4×	1.8k 0.7×	2.1k 0.9×	2.9k 1.2×	279	12.1k
James H. Warram United States	68	6.4k 1.2×	3.8k 1.3×	3.5k 1.4×	3.5k 1.4×	5.2k 2.2×	190	17.3k
Masakazu Haneda Japan	67	5.4k 1.0×	1.1k 0.4×	2.7k 1.1×	4.8k 2.0×	3.5k 1.5×	292	16.1k
Yasuhiko Iwamoto Japan	50	4.9k 0.9×	1.7k 0.6×	2.2k 0.9×	2.8k 1.1×	865 0.4×	272	10.5k
Philip Raskin United States	65	9.8k 1.9×	3.4k 1.2×	4.7k 1.9×	3.6k 1.5×	941 0.4×	272	16.7k
Atsunori Kashiwagi Japan	55	3.5k 0.7×	901 0.3×	2.2k 0.9×	4.2k 1.7×	1.2k 0.5×	231	11.3k
Per‐Henrik Groop Finland	74	9.8k 1.9×	4.1k 1.4×	4.3k 1.7×	5.8k 2.4×	3.5k 1.5×	522	23.0k

Countries citing papers authored by Carol Forsblom

Since Specialization

Citations

This map shows the geographic impact of Carol Forsblom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Forsblom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Forsblom more than expected).

Fields of papers citing papers by Carol Forsblom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Forsblom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Forsblom. The network helps show where Carol Forsblom may publish in the future.

Co-authorship network of co-authors of Carol Forsblom

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Forsblom. A scholar is included among the top collaborators of Carol Forsblom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Forsblom. Carol Forsblom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lithovius, Raija, Stefan Mutter, Erkka Valo, et al.. (2022). Genetic Risk Score Enhances Coronary Artery Disease Risk Prediction in Individuals With Type 1 Diabetes. Diabetes Care. 45(3). 734–741. 4 indexed citations

Frimodt‐Møller, Marie, Andressa de Zawadzki, Ismo Mattila, et al.. (2022). Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Medicine. 11(13). 3573–3573. 27 indexed citations

Parente, Erika B., et al.. (2021). The impact of central obesity on the risk of hospitalization or death due to heart failure in type 1 diabetes: a 16-year cohort study. Cardiovascular Diabetology. 20(1). 153–153. 20 indexed citations

Mutter, Stefan, Erkka Valo, Viljami Aittomäki, et al.. (2021). Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes. Diabetologia. 65(1). 140–149. 39 indexed citations

Parente, Erika B., Valma Harjutsalo, Carol Forsblom, & Per‐Henrik Groop. (2021). Waist-Height Ratio and the Risk of Severe Diabetic Eye Disease in Type 1 Diabetes: A 15-Year Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 107(2). e653–e662. 13 indexed citations

Mäkimattila, Sari, Valma Harjutsalo, Carol Forsblom, & Per‐Henrik Groop. (2020). Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations

Sandholm, Niina, David‐Alexandre Trégouët, Amy Jayne McKnight, et al.. (2020). Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus. Cardiovascular Research. 117(2). 600–612. 15 indexed citations

Guo, Jing, Owen J. L. Rackham, Niina Sandholm, et al.. (2020). Whole-Genome Sequencing of Finnish Type 1 Diabetic Siblings Discordant for Kidney Disease Reveals DNA Variants associated with Diabetic Nephropathy. Journal of the American Society of Nephrology. 31(2). 309–323. 13 indexed citations

Parente, Erika B., Valma Harjutsalo, Markku Lehto, et al.. (2020). Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status. Cardiovascular Diabetology. 19(1). 9 indexed citations

10.

Mutter, Stefan, Erika B. Parente, Valma Harjutsalo, et al.. (2020). Waist-height ratio and waist circumference are the best estimators of visceral fat in type 1 diabetes independently of diabetic nephropathy. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations

11.

Syreeni, Anna, Niina Sandholm, Jingjing Cao, et al.. (2019). Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes. Diabetes. 68(4). 858–867. 14 indexed citations

12.

Feodoroff, Maija, Valma Harjutsalo, Carol Forsblom, & Per‐Henrik Groop. (2018). Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 7 indexed citations

13.

Sandholm, Niina, Jani K. Haukka, Iiro Toppila, et al.. (2018). Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes. Scientific Reports. 8(1). 12408–12408. 12 indexed citations

14.

Kuusela, Sara, Eero Lehtonen, Mervi E. Hyvönen, et al.. (2015). Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway. Cell Death and Disease. 6(5). e1752–e1752. 37 indexed citations

15.

Królewski, Andrzej S., James H. Warram, Carol Forsblom, et al.. (2012). Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes. Diabetes Care. 35(11). 2311–2316. 54 indexed citations

16.

Wessman, Maija, Carol Forsblom, Mari Kaunisto, et al.. (2011). Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes. PLoS ONE. 6(9). e24053–e24053. 10 indexed citations

17.

Ahola, Aila J., et al.. (2010). The cross-sectional associations between sense of coherence and diabetic microvascular complications, glycaemic control, and patients' conceptions of type 1 diabetes. Health and Quality of Life Outcomes. 8(1). 142–142. 21 indexed citations

18.

Vionnet, Nathalie, Michel Marre, Per‐Henrik Groop, et al.. (2006). The canosinase gene (CNDP1) is not a protection factor of diabetic nephropathy in type 1 diabetics. Diabetes & Metabolism. 32. 1 indexed citations

19.

Forsblom, Carol, et al.. (2001). No association between polymorphisms in the nephrin gene and proteinuria in type 1 diabetic patients. 846. 1 indexed citations

20.

Lehto, Markku, Melanie M. Mahtani, Elisabeth Widén, et al.. (1997). Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.. Journal of Clinical Investigation. 99(4). 582–591. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact